Abstract:The conventional mass spectrometry (MS)-based strategy is often inadequate for the comprehensive characterization of various size neuropeptides without the assistance of genomic information. This study evaluated sequence coverage of different size neuropeptides in two crustacean species, blue crab Callinectes sapidus and Jonah crab Cancer borealis using conventional MS methodologies and revealed limitations to mid- and large-size peptide analysis. Herein we attempt to establish a multi-scale strategy for simultaneous and confident sequence elucidation of various sizes of peptides in the crustacean nervous system. Nine novel neuropeptides spanning a wide range of molecular weights (0.9-8.2kDa) were fully sequenced from a major neuroendocrine organ, the sinus gland of the spiny lobster Panulirus interruptus. These novel neuropeptides included seven allatostatin (A- and B-type) peptides, one crustacean hyperglycemic hormone precursor-related peptide, and one crustacean hyperglycemic hormone. Highly accurate multi-scale characterization of a collection of varied size neuropeptides was achieved by integrating traditional data-dependent tandem MS, improved bottom-up sequencing, multiple fragmentation technique-enabled top-down sequencing, chemical derivatization, and in silico homology search. Collectively, the ability to characterize a neuropeptidome with vastly differing molecule sizes from a neural tissue extract could find great utility in unraveling complex signaling peptide mixtures employed by other biological systems. BIOLOGICAL SIGNIFICANCE:Mass spectrometry (MS)-based neuropeptidomics aims to completely characterize the neuropeptides in a target organism as an important first step toward a better understanding of the structure and function of these complex signaling molecules. Although liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) with data-dependent acquisition is a powerful tool in peptidomic research, it often lacks the capability for de novo sequencing of mid-size and large peptides due to inefficient fragmentation of peptides larger than 4kDa. This study describes a multi-scale strategy for complete and confident sequence elucidation of various sizes of neuropeptides in the crustacean nervous system. The aim is to fill a technical gap where the conventional strategy is inefficient for comprehensive characterization of a complex neuropeptidome without assistance of genomic information. Nine novel neuropeptides in a wide range of molecular weights (0.9-8.2kDa) were fully sequenced from a major neuroendocrine organ of the spiny lobster, P. interruptus. The resulting molecular information extracted from such multi-scale peptidomic analysis will greatly accelerate functional studies of these novel neuropeptides.

In Situ Identification and Mapping of Neuropeptides from the Stomatogastric Nervous System of Cancer Borealis.

Mapping of Neuropeptides in the Crustacean Stomatogastric Nervous System by Imaging Mass Spectrometry

Combining Microdialysis, NanoLC-MS, and MALDI-TOF/TOF to Detect Neuropeptides Secreted in the Crab, Cancer Borealis.

Mass Spectral Charting of Neuropeptidomic Expression in the Stomatogastric Ganglion at Multiple Developmental Stages of the Lobster Homarus Americanus

Expanding the Crustacean Neuropeptidome Using a Multifaceted Mass Spectrometric Approach.

Measurement of neuropeptides in crustacean hemolymph via MALDI mass spectrometry

Comparative Neuropeptidomic Analysis of Food Intake Via A Multifaceted Mass Spectrometric Approach

Neuropeptidomic Profiling and Localization in the Crustacean Cardiac Ganglion Using Mass Spectrometry Imaging with Multiple Platforms

A multi-scale strategy for discovery of novel endogenous neuropeptides in the crustacean nervous system.

Mass spectral analysis of neuropeptide expression and distribution in the nervous system of the lobster Homarus americanus.

Capillary electrophoresis coupled to MALDI mass spectrometry imaging with large volume sample stacking injection for improved coverage of C. borealis neuropeptidome

Three Dimensional Mapping of Neuropeptides and Lipids in Crustacean Brain by Mass Spectral Imaging

Distribution and Physiological Effects of B‐type Allatostatins (myoinhibitory Peptides, MIPs) in the Stomatogastric Nervous System of the Crab Cancer Borealis

Mass Spectrometric Imaging of Neuropeptides in Decapod Crustacean Neuronal Tissues.

Combining Bottom-Up And Top-Down Mass Spectrometric Strategies For De Novo Sequencing Of The Crustacean Hyperglycemic Hormone From Cancer Borealis

Molecular cloning of crustacean hyperglycemic hormone (CHH) family members (CHH, molt-inhibiting hormone and mandibular organ-inhibiting hormone) and their expression levels in the Jonah crab, Cancer borealis

Defining the Neuropeptidome of the Spiny Lobster Panulirus Interruptus Brain Using a Multidimensional Mass Spectrometry-Based Platform

Mass Spectral Characterization of Peptide Transmitters/hormones in the Nervous System and Neuroendocrine Organs of the American Lobster Homarus Americanus

Investigation of Signaling Molecules and Metabolites Found in Crustacean Hemolymph Via in Vivo Microdialysis Using a Multifaceted Mass Spectrometric Platform

Comparison of NIMS and MALDI Platforms for Neuropeptide and Lipid Mass Spectrometric Imaging in C. Borealis Brain Tissue

Functional Characterization and Signaling Systems of Corazonin and Red Pigment Concentrating Hormone in the Green Shore Crab, Carcinus maenas